Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deping Wang

Showing results (151-160 of 165) with videos related to

Pageof 17
Sort By:
Bioorganic & Medicinal Chemistry Letters|October 28, 2008
Design at the atomic level: generation of novel hybrid biaryloxazolidinones as promising new antibioticsJiacheng Zhou, Ashoke Bhattacharjee, Shili Chen, et al.
ACS Medicinal Chemistry Letters|August 22, 2018
Structure-Guided Design and Procognitive Assessment of a Potent and Selective Phosphodiesterase 2A InhibitorShawn J Stachel, Richard Berger, Ashley B Nomland, et al.
Journal of Medicinal Chemistry|January 11, 2013
Identification of GZD824 as an orally bioavailable inhibitor that targets phosphorylated and nonphosphorylated breakpoint cluster region-Abelson (Bcr-Abl) kinase and overcomes clinically acquired mutation-induced resistance against imatinibXiaomei Ren, Xiaofen Pan, Zhang Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|February 14, 2012
Synthesis, SAR and biological evaluation of 1,6-disubstituted-1H-pyrazolo[3,4-d]pyrimidines as dual inhibitors of Aurora kinases and CDK1Jean-Yves Le Brazidec, Angela Pasis, Betty Tam, et al.
Bioorganic & Medicinal Chemistry|May 8, 2013
Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanismDouglas Marcotte, Weike Zeng, Jean-Christophe Hus, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2023
Identification, structural, and biophysical characterization of a positive modulator of human Kv3.1 channelsYun-Ting Chen, Mee Ra Hong, Xin-Jun Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|March 15, 2018
Indole acids as a novel PDE2 inhibitor chemotype that demonstrate pro-cognitive activity in multiple speciesShawn J Stachel, Melissa S Egbertson, Jenny Wai, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
Structure-based design of 2,6,7-trisubstituted-7H-pyrrolo[2,3-d]pyrimidines as Aurora kinases inhibitorsJean-Yves Le Brazidec, Angela Pasis, Betty Tam, et al.
Bioorganic & Medicinal Chemistry Letters|November 9, 2017
The identification of a novel lead class for phosphodiesterase 2 inhibition by fragment-based drug designAshley B Forster, Pravien Abeywickrema, Jaime Bunda, et al.
ACS Medicinal Chemistry Letters|June 18, 2021
Discovery of Arylsulfonamide Na<sub>v</sub>1.7 Inhibitors: IVIVC, MPO Methods, and Optimization of Selectivity ProfileAnthony J Roecker, Mark E Layton, Joseph E Pero, et al.
Pageof 17

Showing results (151-160 of 165) with videos related to

Sort By:
Pageof 17
Bioorganic & Medicinal Chemistry Letters|October 28, 2008
Design at the atomic level: generation of novel hybrid biaryloxazolidinones as promising new antibioticsJiacheng Zhou, Ashoke Bhattacharjee, Shili Chen, et al.
ACS Medicinal Chemistry Letters|August 22, 2018
Structure-Guided Design and Procognitive Assessment of a Potent and Selective Phosphodiesterase 2A InhibitorShawn J Stachel, Richard Berger, Ashley B Nomland, et al.
Journal of Medicinal Chemistry|January 11, 2013
Identification of GZD824 as an orally bioavailable inhibitor that targets phosphorylated and nonphosphorylated breakpoint cluster region-Abelson (Bcr-Abl) kinase and overcomes clinically acquired mutation-induced resistance against imatinibXiaomei Ren, Xiaofen Pan, Zhang Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|February 14, 2012
Synthesis, SAR and biological evaluation of 1,6-disubstituted-1H-pyrazolo[3,4-d]pyrimidines as dual inhibitors of Aurora kinases and CDK1Jean-Yves Le Brazidec, Angela Pasis, Betty Tam, et al.
Bioorganic & Medicinal Chemistry|May 8, 2013
Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanismDouglas Marcotte, Weike Zeng, Jean-Christophe Hus, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2023
Identification, structural, and biophysical characterization of a positive modulator of human Kv3.1 channelsYun-Ting Chen, Mee Ra Hong, Xin-Jun Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|March 15, 2018
Indole acids as a novel PDE2 inhibitor chemotype that demonstrate pro-cognitive activity in multiple speciesShawn J Stachel, Melissa S Egbertson, Jenny Wai, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
Structure-based design of 2,6,7-trisubstituted-7H-pyrrolo[2,3-d]pyrimidines as Aurora kinases inhibitorsJean-Yves Le Brazidec, Angela Pasis, Betty Tam, et al.
Bioorganic & Medicinal Chemistry Letters|November 9, 2017
The identification of a novel lead class for phosphodiesterase 2 inhibition by fragment-based drug designAshley B Forster, Pravien Abeywickrema, Jaime Bunda, et al.
ACS Medicinal Chemistry Letters|June 18, 2021
Discovery of Arylsulfonamide Na<sub>v</sub>1.7 Inhibitors: IVIVC, MPO Methods, and Optimization of Selectivity ProfileAnthony J Roecker, Mark E Layton, Joseph E Pero, et al.
Pageof 17